Results 191 to 200 of about 28,615 (209)

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Lancet, The, 2013
John J Bissler, Elzbieta Radzikowska, Norio Nonomura   +2 more
exaly  

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Lancet, The, 2016
Jacqueline A French, Paolo Curatolo, Petrus J De Vries   +2 more
exaly  

Tuberous sclerosis

Lancet, The, 2008
Paolo Curatolo, Sergiusz Jozwiak
exaly  

The Tuberous Sclerosis Complex

New England Journal of Medicine, 2006
Peter B Crino, Katherine L Nathanson
exaly  

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

New England Journal of Medicine, 2008
John J Bissler, Francis X Mccormack, David N Franz   +2 more
exaly  

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

New England Journal of Medicine, 2010
Darcy A Krueger, David N Franz
exaly  

Tuberous sclerosis complex

Nature Reviews Disease Primers, 2016
Elizabeth P Henske, Sergiusz Jozwiak, Julian R Sampson   +2 more
exaly  

Seizures in tuberous sclerosis complex: hitting the target

Lancet, The, 2016
E Steve Roach, David J Kwiatkowski
exaly  

Neurological and neuropsychiatric aspects of tuberous sclerosis complex

Lancet Neurology, The, 2015
Paolo Curatolo, Romina Moavero, Petrus J De Vries   +2 more
exaly  

Prevalence of tuberous sclerosis estimated by capture-recapture analysis

Lancet, The, 1998
Finbar Jk O'callaghan
exaly